AngioDynamics Settles Multi-Year Patent Dispute with Becton Dickinson & Co
By Sabela Ojea
AngioDynamics entered a settlement agreement with Becton Dickinson & Co. to resolve multi-year patent litigation with its affiliate C.R. Bard.
Under the settlement, BD will grant a license to AngioDynamics under some of its port patents and AngioDynamics will grant BD a license under certain of AngioDynamics' catheter patents.
The provider of medical devices has agreed to pay a one-time lump sum payment to BD of $7 million and six minimum annual payments of $2.5 million, with potential additional payments if 6% of annual net sales of AngioDynamics' port products exceed the minimum payment.
"We are pleased to bring this long-standing litigation to a successful conclusion that will reduce our ongoing legal spend and lift a more than ten-year distraction to the Company," Chief Executive Jim Clemmer said.
Write to Sabela Ojea at sabela.ojea@wsj.com; @sabelaojeaguix
(END) Dow Jones Newswires
April 01, 2024 18:08 ET (22:08 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s Happening in the Markets This Week
-
Worst-Performing Stock ETFs of the Quarter
-
Q3 in Review and Q4 2024 Market Outlook
-
Top-Performing Stock ETFs of the Quarter
-
September Jobs Report Forecasts Show Moderate Hiring Gains
-
Port Strike a Headache for Shippers but a Potential Tailwind for Certain US Transport Stocks
-
13 Charts on Q3′s Roller-Coaster Rally for Stocks and Bonds
-
5 Stocks to Buy Instead of Overpriced US Equities
-
Consumer Defensives: Despite Angst, Thirsty Investors Have Names to Pursue
-
Industrials: Many Stocks Overvalued After Q3 Outperformance
-
Basic Materials: Despite Index Rise, We See Multiple Long-Term Opportunities
-
What the Election Could Mean for Big Tech Stocks
-
3 Lessons From Recent Stock Market Drama
-
Consumer Cyclicals: Even Amid Moderating Consumer Spending, We See Discounts
-
Healthcare: Valuations Look Fair Overall, With Select Industries Still Undervalued
-
Utilities: Falling Interest Rates, Growth Outlook Boosting Stocks